BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 11, 2015
View Archived Issues
Scientists report new data on the expression of PD-1 and its ligands in MPM
Read More
Novel mutations linked to retinitis pigmentosa
Read More
Elite Pharmaceuticals and Epic Pharma enter into agreement for abuse-deterrent ELI-200
Read More
SAGE-547 eliminates postpartum depression in exploratory trial
Read More
Dosing for bone marrow chemoprotection studied with G1T28
Read More
Merck KGaA, Illumina and Genea establish Global Fertility Alliance
Read More
PEP-Therapy and CleveXel Pharma partner on development of targeted therapy in oncology
Read More
NeuPharma begins phase I trial of RX-108
Read More
Imaging agent 68Ga-NOTA-NFB found safe in volunteers and patients with glioma
Read More
Lycera and Celgene establish strategic collaboration
Read More
Mutations in MSDF8 linked to macular dystrophy
Read More
The State University of New York patents antituberculosis benzimidazoles
Read More
Lilly discloses DGAT2 inhibitors
Read More
PTC Therapeutics introduces BMI-1 inhibitors
Read More
Pharmakea patents autotaxin inhibitors
Read More
Bristol-Myers Squibb discloses EZH2 inhibitors
Read More
Selecta Biosciences begins phase I program of SEL-212 for gout
Read More
FDA grants orphan drug designation to Isarna's ISTH-0036
Read More
Goodwin partners with Aspyrian on GMP manufacturing of RM-1929
Read More
FDA awards orphan drug designation to AG-120 for AML
Read More
U.S. orphan drug designation awarded to LN-144 for malignant melanoma
Read More
Arrowhead's ARC-AAT obtains FDA orphan drug designation for AATD-associated liver disease
Read More
BMS selects drug candidate from PeptiDream discovery collaboration
Read More
Roche receives FDA breakthrough therapy designation for Actemra in systemic sclerosis
Read More
Experiments support weekly administration of long-acting insulin product AB-101 for diabetes
Read More
Ziarco's ZPL-389 enters phase IIa trial in patients with atopic dermatitis
Read More